Discontinuation report TERAZOSIN

Last updated on 2021-12-16 History
Report ID 151275
Drug Identification Number 02350505
Brand name TERAZOSIN
Common or Proper name TERAZOSIN
Company Name SANIS HEALTH INC
Market Status DORMANT
Active Ingredient(s) TERAZOSIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-03-01
Actual discontinuation date
Remaining supply date
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-12-16 French Compare
v3 2021-12-16 English Compare
v2 2021-12-16 French Compare
v1 2021-12-16 English Compare

Showing 1 to 4 of 4